By regulating gene expression of inflammatory pathway inhibitors such as Trem2, S/G lipids merit broader investigation into the potential dysfunction of other innate immune cells, such as microglia, in diseases such as Alzheimer’s disease (37, 38). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.